IXHL Incannex Healthcare Inc.
-
Incannex Healthcare Beat Consensus Estimates
Friday, May 15, 2026 · 12:00 AM ET
Incannex Healthcare (IXHL) reported a loss of $0.35 per share on revenue of $0.00 million for the fiscal third quarter ended March 2026. The consensus estimate was a loss of $0.60 per share on revenue of $40.00 million. The company beat consensus estimates by 41.67%.
Incannex Healthcare Limited is a clinical-stage pharmaceutical company developing unique medicinal cannabis pharmaceutical products and psychedelic medicine therapies for unmet medical needs. Incannex Healthcare Limited is based in MELBOURNE, Australia.
Earnings Whisper Grade
—
Power Rating—
Reported Earnings
($0.35)
Earnings Whisper®
—
Consensus Estimate
($0.60)
Earnings Surprise
Earnings Growth
Reported Revenue
—
Revenue Estimate
$40.00M
Revenue Surprise
Revenue Growth—